When is enrollment in clinical trials indicated for the treatment of renal cell carcinoma (RCC)?

Updated: May 21, 2019
  • Author: Kush Sachdeva, MD; Chief Editor: E Jason Abel, MD  more...
  • Print
Answer

The treatment of metastatic renal cell carcinoma is problematic, so whenever possible, patients should be directed to approved and controlled clinical trials. This applies as well in the adjuvant treatment of surgically resected renal cell carcinoma, for which no therapy has yet been found to offer survival benefit.

Go to Renal Cell Carcinoma Treatment Protocols, Clear Cell Renal Cell Carcinoma, and Sarcomatoid and Rhabdoid Renal Cell Carcinoma for complete information on these topics.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!